ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

Full Text Of Saffiotti’s Statement

May 7, 1976

Substance From Sea Squirts In Phase II For Breast Cancer

November 29, 2002